Sarepta Therapeutics Operating Expenses 2010-2024 | SRPT

Sarepta Therapeutics operating expenses for the twelve months ending September 30, 2024 were $1.559B, a 3.66% increase year-over-year.

  • Sarepta Therapeutics annual operating expenses for 2023 were $1.511B, a 2.85% increase from 2022.
  • Sarepta Therapeutics annual operating expenses for 2022 were $1.469B, a 26.48% increase from 2021.
  • Sarepta Therapeutics annual operating expenses for 2021 were $1.162B, a 5.19% increase from 2020.

Sarepta Therapeutics Operating Expenses 2010-2024 | SRPT

  • Sarepta Therapeutics annual operating expenses for 2023 were $1.511B, a 2.85% increase from 2022.
  • Sarepta Therapeutics annual operating expenses for 2022 were $1.469B, a 26.48% increase from 2021.
  • Sarepta Therapeutics annual operating expenses for 2021 were $1.162B, a 5.19% increase from 2020.